| pubmed-article:15641027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C0023413 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C2931822 | lld:lifeskim |
| pubmed-article:15641027 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:15641027 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15641027 | pubmed:dateCreated | 2005-2-15 | lld:pubmed |
| pubmed-article:15641027 | pubmed:abstractText | Nasopharyngeal carcinoma (NPC) is rare in children, accounting for <1% of all cases. Treatment most commonly includes radiotherapy but long-term side effects of such treatment can produce devastating cosmetic and functional sequelae in children. Chemotherapy may help to decrease the radiotherapy dose and limit the side effects of local therapies. However, little is known regarding the chemosensitivity of NPC tumors in pediatric patients. | lld:pubmed |
| pubmed-article:15641027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15641027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15641027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15641027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15641027 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15641027 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:SwansonGregor... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:Rodriguez-Gal... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:PappoAlberto... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:DouglassEdwin... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:CastleberryRo... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:LondonWendy... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:FontanesiJame... | lld:pubmed |
| pubmed-article:15641027 | pubmed:author | pubmed-author:WoffordMarcia... | lld:pubmed |
| pubmed-article:15641027 | pubmed:copyrightInfo | Copyright (c) 2005 American Cancer Society. | lld:pubmed |
| pubmed-article:15641027 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15641027 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15641027 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:15641027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15641027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15641027 | pubmed:pagination | 850-7 | lld:pubmed |
| pubmed-article:15641027 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:meshHeading | pubmed-meshheading:15641027... | lld:pubmed |
| pubmed-article:15641027 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15641027 | pubmed:articleTitle | Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. | lld:pubmed |
| pubmed-article:15641027 | pubmed:affiliation | Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. carlos.rodriguez-galindo@stjude.org | lld:pubmed |
| pubmed-article:15641027 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15641027 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15641027 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641027 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641027 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15641027 | lld:pubmed |
